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============

Carpal tunnel syndrome (CTS) which is caused by compression of the median nerve at the wrist with the carpal tunnel boundary is the most common and widely studied nerve entrapment neuropathy in the upper extremity.\[[@ref1][@ref2]\] Due to variations in diagnostic criteria used, the prevalence of CTS reported very widely, and it seems that 10% of general population, clinically, develops CTS at some point.\[[@ref3]\] It can have substantial physical, psychological, and economic consequences.\[[@ref4][@ref5]\] Several therapies ranging from nonsurgical to surgical treatments are available to treat and manage CTS. Surgical therapies may be indicated when conservative treatment fails.\[[@ref6]\]

The surgical treatment of CTS is consisting of releasing carpal tunnel content by transection of the transverse carpal ligament. Although this method is known as the most effective treatment of CTS, surgical complications are reported to occur in these patients.\[[@ref1]\] Serious complications comprising structural damage to the nerves, arteries, and tendons are rare and based on surgical methods reported between 0.19% and 0.5%.\[[@ref7]\] Pillar pain, scar tenderness, transient neuropraxia, and reoperation are among the other common complications of surgical treatment of CTS and can result in delayed return to work and cause decline of health-related quality of life.\[[@ref8]\] Pillar pain, which is known as the pain between the thenar and hypothenar areas of the hand, is reported as the most common complication after surgical treatment of CTS, whereas regardless of the surgical technique, the occurrence was estimated between 6% and 36%.\[[@ref6]\] Although rest, bracing, and physiotherapy are usual treatment methods of pillar pain, painful symptoms are reported insignificant number of patients after surgery.\[[@ref9]\]

Extracorporeal shockwave therapy (ESWT) which includes a sequence of single sound impulses characterized by a high-pressure peak and quick pressure rise in a short duration was applied to patients for the first time to break up kidney stones.\[[@ref10][@ref11]\] ESWT, due to its angiogenic, analgesic, and anti-inflammatory effects, has been successfully used to treat a variety of musculoskeletal diseases.\[[@ref12][@ref13][@ref14][@ref15]\] Furthermore, it has shown promising effects in conservative treatment of mild-to-moderate CTS.\[[@ref16]\] Even in comparison with steroid injection, pain score has been reduced more with ESWT in preoperative treatment of patients with CTS.\[[@ref17]\]

To date, only one study conducted by Romeo *et al*. has described the efficacy of low energy flux density shockwaves in treating pillar pain after CTS surgery. They applied the ESWT in patients who had pillar pain after CTS surgery and showed that pillar pain significantly decreased after the intervention.\[[@ref9]\] It means that, Romeo *et al*.\[[@ref9]\] have shown the beneficial effect of ESWT on pillar pain though they did not have any control group to compare their results. On this basis, this randomized controlled trial was designed to evaluate the effects of ESWT in treating pillar pain after CTS surgery.

Materials and Methods {#sec1-2}
=====================

Between June, 2017 and January, 2018, 34 patients who had pillar pain after median nerve release for CTS were enrolled and studied in this prospective randomized controlled trial. Patients were selected from Kashani hospital in Isfahan, Iran. The surgery was performed by a single surgeon, and all patients received the same surgical treatment through an open incision at the palmar crease of the wrist, followed by a complete release of the transverse carpal ligament. All of the patients received ten sessions of same physical therapy before referral. Pillar pain was diagnosed by a single evaluator by using three clinical tests which included, increasing pain with hand grip, application of direct pressure on the thenar and hypothenar regions (by applying approximately 2-kg force of pinch to the palm with the thumb on the anterior side and index finger on the dorsal side of the wrist) and the so-called "table test," where the patient places their hands on the edge of a table, leaning their weight on their hands.

Persistent palmar pain for at least 1 month after surgery and visual analog scale (VAS) \>5 points were the inclusion criteria. And also, patients with a history of double crush syndrome, diabetes mellitus, skin diseases, infection at the site of treatment, pregnancy, coagulopathy, systemic diseases with joint involvement such as gout, rheumatoid arthritis, and peripheral vascular diseases were excluded from the study. The study protocol was approved by the Institutional Review Board and Ethics Committee of Isfahan University of Medical Sciences, and all patients signed an informed consent form before the study.

Eligible patients were randomly distributed into two equal groups; ESWT group and control group. In ESWT group, each patient received ESWT, one session per week, up to 4 weeks, using ESWT device (the standard electromagnetic DUOLITH SD1, Storz Medical, Tägerwilen, Switzerland). The ESWT was done with an average of 2800 shocks (with focus probe) and very low energy flux density of 0.03 mJ/mm^2^ at first session. The energy was increased during the next three sessions according to patients' tolerance. The pulse repetition frequency was 4 Hz. Patient was relaxed sitting and his forearm was placed on the table with the palm facing up, and the ESWT device probe was oriented perpendicular on the area of subcutaneous swelling and skin redness or otherwise if redness or edema were not present, in the area between the thenar and hypothenar eminences. Patients in the control group received sham ESWT treatment for the same interval, involved sound but no energy.

Study end-points were patients hand function and pain score. Hand function was assessed by a brief version of the Michigan Hand Outcome Questionnaire (Brief-MHQ) which contains 12 items in 5-Likert scale regarding several aspects of hand function. The summary score of the Brief-MHQ was between 0 and 100, whereas, higher scores indicate better overall functioning and satisfaction. Pain score was estimated by VAS using a vertical line with 10-cm length on paper (rating scale where 0 = absence of pain and 10 = worst imaginable pain). To assess the end-points, patients in both groups were visited and followed at baseline, 1^st^ month, and 3^rd^ month after the end of treatment.

Statistical analyses were done using SPSS software (SPSS, Inc., Chicago, IL, USA, Version 23). Descriptive data are reported as mean ± standard deviation independent sample *t*-test was used to compare pain score and brief-MHQ score between groups. Repeated measurements of ANOVA, was used to compare the trend of pain score and brief-MHQ score within the group and between groups. The level of significance is considered to be \<0.05.

Results {#sec1-3}
=======

[Figure 1](#F1){ref-type="fig"} shows the flowchart of the study. To select eligible patients, 40 patients were reviewed. Six patients did not enter (four patients refused informed consent, and two were not eligible). Thirty-four eligible patients assigned into two ESWT and control groups. All the patients were completed the 3 months of the follow-up period and were included in final analyses. All patients in ESWT group were female with the mean age of 49.9 ± 11.8 years old. In the control group, the mean of age was 46.3 ± 8.1 years old and 16 patients (94%) were female.

![Flowchart of the study](ABR-8-31-g001){#F1}

Pain score and MHQ score at baseline, 1^st^, and 3^rd^ month were compared between ESWT and control groups and results are presented in [Table 1](#T1){ref-type="table"}. Pain score at baseline in both groups was similar but after 1 month in ESWT group was 3.7 and in control group was 4.7, this difference between groups was not statistically significant (*P* = 0.066), after 3 months, pain score in ESWT group was significantly lower than control group (1.6 vs. 3.6, respectively, *P* \< 0.0001). Pain score in both groups was significantly decreased during the study period, although this decrease in the ESWT group was significantly more than the control group \[[Figure 2](#F2){ref-type="fig"}\], (*P* = 0.038). MHQ score at baseline was not significantly different between groups (*P* = 0.559). After 1^st^ month, MHQ score in ESWT group was significantly more than the control group (60.7 vs. 52.2, respectively, *P* = 0.032). After 3 months, MHQ score in ESWT group was 75.4 and in control group was 63.7 (*P* \< 0.0001). The increase in MHQ score during the study period within both groups was statistically significant. However, trend of increase in MHQ score during the study, between ESWT and control groups was not significantly different \[[Figure 2](#F2){ref-type="fig"}\], (*P* = 0.186).

###### 

Comparison of pain score and Michigan Hand Outcome Questionnaire score between studied groups

  End-points        ESWT group   Control group   *P*^b^
  ----------------- ------------ --------------- ----------
  Pain VAS score                                 
   Baseline         5.9±2        6.1±1.9         0.791
   First month      3.7±1.6      4.7±1.4         0.066
   Third month      1.8±0.8      3.6±1.1         \<0.0001
   *P*^a^           \<0.0001     \<0.0001        
  Brief-MHQ score                                
   Baseline         37.5±16.5    40.7±15         0.559
   First month      60.7±11.2    52.2±10.8       0.032
   Third month      75.4±6.5     63.7±6.3        \<0.0001
   *P*^a^           \<0.0001     \<0.0001        

Data are mean±SD. *P*^a^: Assessed trend of variables during the study period within groups using repeated measurements of ANOVA, *P*^b^: Assessed variables between groups at each time points using one way of ANOVA. SD: Standard deviation, VAS: Visual analog scale, MHQ: Michigan Hand Outcome Questionnaire, ESWT: Extracorporeal shock wave therapy

![Trend of pain score and Michigan Hand Outcome Questionnaire score during the study period between groups by repeated measurements of ANOVA](ABR-8-31-g002){#F2}

[Figure 3](#F3){ref-type="fig"} shows the comparison of changes in pain score and MHQ score between ESWT and control groups. The mean of changes in pain score and MHQ score after 1^st^ month in comparison with baseline in ESWT group were significantly more than control groups (*P* = 0.031 and 0.002, respectively). The mean of changes in pain score after three months compared to baseline in ESWT group was −4.1 and in control group was −2.5 (*P* = 0.006). Furthermore, the mean of changes in MHQ score after 3 months in comparison with baseline in the ESWT group was significantly more than the control group (37.9 vs. 21.6, respectively, *P* = 0.007).

![Comparison of changes in pain score and Michigan Hand Outcome Questionnaire score between studied groups by independent sample *t*-test](ABR-8-31-g003){#F3}

Discussion {#sec1-4}
==========

In the present study, pillar pain as a common surgical complication in patients with CTS was treated by ESWT (one session each week for 4 weeks) and findings were compared with control patients. Hand function and pain score in both ESWT and control group improved during study period. Hand function 1 and 3 months after the end of the treatment in ESWT group was significantly better than control group but pain score in month 3 in ESWT group was significantly better than control group.

Although hand function and pain score in control group were improved during study, ESWT showed a faster recovery in hand function and pain score. The improvement in control group can be explained by placebo effect or period effect, where it is reported that pillar pain is occurred in 41% of patients at 1 month, 25% at 3 months, 6% at 12 months, and 6% at 36 months after surgery.\[[@ref18]\] In our study, all patients in ESWT group, at 3 months after treatment, had a VAS score ≤3, whereas in control group, more than half of the patients reported VAS score higher than 3. In addition, the increase in hand function score in ESWT group 4 weeks after treatments was twice that of control group and at 3 months after treatment the difference was \>50%. Considering the fact that, our sample size was low and only 34 patients in two groups of ESWT and control were evaluated, our findings show that ESWT, as a noninvasive treatment, is safe and effective for pillar pain after carpal tunnel release.

Although the previous studies have shown the successful effects of ESWT in the treatment of several painful inflammatory soft-tissue conditions,\[[@ref12][@ref19]\] the efficacy of ESWT in treating pillar pain after carpal tunnel release has described by Romeo *et al*. in preliminary and noncontrolled study. In this study, 40 patients who had pillar pain after carpal tunnel release were treated using ESWT and showed that in all of the treated patients, pain score and redness and swelling of the surgical scar significantly improved 120 days after treatment. Romeo *et al*. concluded a noncontrolled study and the patients were assessed in one group, where after treatment outcomes were compared to before treatment and also they used ESWT once a week for 4 weeks and patients were followed for 4 months.\[[@ref9]\] In our study, patients in ESWT group received four weekly sessions of ESWT, were followed for 3 months and treatment outcomes were compared with control group, but despite the existing differences, both studies show the same results with regard to the effect of the ESWT on pillar pain.

The etiology of pillar pain is still unknown, while surgical factors, ligamentous and muscular conditions, biomechanical imbalance, and neurogenic inflammation have highlighted as possible causes.\[[@ref18][@ref20][@ref21][@ref22][@ref23]\] In the other hand, the possible mechanism of action in ESWT is not completely understood and is still being studied, however, the ability of shockwaves in significant increase in nitric oxide inducing and a decrease in pro-inflammatory substances, or its ability in reduction of the number of cutaneous nerve fibers and the immunoreactivity to the calcitonin gene-related peptide has shown in experimental studies.\[[@ref19][@ref24]\] Hence, acoustic stimulation of living tissues seems to influence the complex nitric oxide pathway, which is able to modulate inflammation by an angiogenic and trophic effect.\[[@ref20][@ref24]\]

Conclusion {#sec1-5}
==========

The results of the present study revealed that hand function and pain score in patients with pillar pain after carpal tunnel release improved faster in those who received ESWT compared to control patients. Therefore, because of the noninvasive nature of ESWT, it can be a useful technique for improvement of pillar pain in patients with CTS. Of course future studies with larger sample size, seem necessary to validate our results.
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